Thus, reprogramming the behaviors of TAMs to unleash their anti-tumor potential, thereby antagonizing the immunosuppressive TME and effectively activating cytotoxic CD8+ T cells, is increasingly recognized as a critical component of effective anti-tumor strategies. This evidence concerns the gene CD8A and neoplasm.